What are the anticoagulation options for intermittent hemodialysis? - Nature Reviews Nephrology

Clicks: 286
ID: 270841
2011
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #1 of 2 articles by views in nature reviews nephrology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Low-molecular-weight heparins are replacing unfractionated heparin as the anticoagulant of choice for patients receiving hemodialysis. However, clotting can still be a problem during hemodialysis. This Review discusses the different anticoagulant options for these patients.
Reference Key
andrew2011naturewhat Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Davenport, Andrew;Davenport, Andrew;
Journal nature reviews nephrology
Year 2011
DOI
doi:10.1038/nrneph.2011.88
URL
https://dx.doi.org/10.1038%2Fnrneph.2011.88
Keywords
chronic kidney disease clinical pharmacology haemodialysis

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.